RxDoctor Payments Data

Kimberly O'Dell, NP

Family · Scarborough, MENPI 1982123527

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,189 of the $1,558 with a category attached, or 76.3%. Edwards Lifesciences accounts for 64.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $926 and has fallen 97.7% since, to $21 in 2025. Among family clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,558in general payments, 2019–2025

Across 25 payments — averaging $62.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1K
  • Boston Scientific$309
  • Amgen$114
  • Abbott$42
  • E.r. Squibb & Sons, L.L.C.$23
  • Johnson & Johnson$23
  • plus $40 from 2 others

What the payments were for

  • Travel & lodging$36824%
  • Food & beverage$1,18976%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,558 in reported general payments places this provider in the 90th percentile of 545 family providers in Maine.

See all family providers in Maine

Medicare billing

Part B allowed, 2024
$32,724
Medicare patients
250
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor12$6,037
ClopidogrelClopidogrel Bisulfate74$696
Metoprolol Succinate14$64

Paid to pharmacies, not to this prescriber.

Other family in Scarborough

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →